Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine-or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study - Osterlund, P; Kinos, S; Pfeiffer, P (ESMO Open, 2022)
et al.